Safety, Tolerability, Pharmacodynamic and Pharmacokinetics of 7.5, 10, 12.5 or 15 mg NRL001 in a 2 g Suppository for 14 Days

Clinical trial NCT01099670 · COMPLETED

Trial details

NCT number: NCT01099670
Sponsor: Norgine
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Fecal Incontinence

Start date: 2010-03-01
Primary completion: 2010-06-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.